Our data showed that the SIRT1 acts as a negative regulator of NFκB function in TB-treated livers as seen by an increased nuclear association between SIRT-1 and p65 with a significant decrease in acetylation at K310 and subsequent decreased recruitment to CCL2 promoter. Here, NFKB1 is linked to tuberculosis.